Male Germ Cell Tumor

Networked: 9 relevant articles (0 outcomes, 1 trials/studies)

Disease Context: Research Results

Neoplasms: 1324753
- Neoplasms by Site: 4
  - Urogenital Neoplasms: 471
    - Male Genital Neoplasms
      - Testicular Neoplasms: 6597
        Male Germ Cell Tumor: 9
  - Endocrine Gland Neoplasms: 130
    - Testicular Neoplasms: 6597
      - Male Germ Cell Tumor: 9
- Neoplasms by Histologic Type: 2
  - Germ Cell and Embryonal Neoplasms: 4454
    - Male Germ Cell Tumor: 9
Urogenital Diseases: 126
Endocrine System Diseases: 968
- Endocrine Gland Neoplasms: 130
  - Testicular Neoplasms: 6597
    - Male Germ Cell Tumor: 9
- Gonadal Disorders: 30
  - Testicular Diseases: 49
    - Testicular Neoplasms: 6597
      - Male Germ Cell Tumor: 9

Related Diseases

1.	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
2.	Neoplasms (Cancer)
3.	Tinnitus

Experts

1.	Fujisawa, Masato: 3 articles (10/2006 - 12/2005)
2.	Hara, Isao: 3 articles (10/2006 - 12/2005)
3.	Yamada, Yuji: 3 articles (10/2006 - 12/2005)
4.	Furukawa, Junya: 2 articles (10/2006 - 12/2005)
5.	Kumano, Masafumi: 2 articles (10/2006 - 12/2005)
6.	Miyake, Hideaki: 2 articles (10/2006 - 08/2006)
7.	Yamanaka, Kazuki: 2 articles (10/2006 - 12/2005)
8.	Ardeshir-Rouhani-Fard, Shirin: 1 article (10/2016)
9.	Beard, Clair J: 1 article (10/2016)
10.	Budnick, Amy: 1 article (10/2016)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Male Germ Cell Tumor:

1.	Cisplatin (Platino)FDA LinkGeneric 05/07/1998 - "Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation." 10/01/2016 - "Comprehensive audiological measures were conducted on 488 North American male germ cell tumor (GCT) survivors in relation to cumulative cisplatin dose, including audiograms (0.25 to 12 kHz), tests of middle ear function, and tinnitus. " 05/18/2004 - "Male germ cell tumor (GCT) is a highly curable malignancy, which exhibits exquisite sensitivity to cisplatin treatment. " 01/01/1986 - "We conducted a phase II clinical trial using ifosfamide (IFX) as a single agent in cisplatin-refractory male germ cell tumor. "
2.	Ifosfamide FDA LinkGeneric 01/01/1986 - "We conducted a phase II clinical trial using ifosfamide (IFX) as a single agent in cisplatin-refractory male germ cell tumor. " 10/01/2006 - "Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience."
3.	Paclitaxel (Taxol)FDA LinkGeneric 12/01/2005 - "To evaluate the feasibility and usefulness of high dose chemotherapy including paclitaxel (T-ICE) combined with peripheral blood stem cell transplantation (PBSCT) for male germ cell tumor. " 12/01/2005 - "High dose chemotherapy including paclitaxel (T-ICE) combined with peripheral blood stem cell transplantation for male germ cell tumor. "
4.	Carboplatin (JM8)FDA LinkGeneric 10/01/2006 - "Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience."
5.	IceIBA 12/01/2005 - "To evaluate the feasibility and usefulness of high dose chemotherapy including paclitaxel (T-ICE) combined with peripheral blood stem cell transplantation (PBSCT) for male germ cell tumor. " 12/01/2005 - "High dose chemotherapy including paclitaxel (T-ICE) combined with peripheral blood stem cell transplantation for male germ cell tumor. "
6.	Etoposide (VP 16)FDA LinkGeneric 10/01/2006 - "Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience."
7.	Bleomycin (Blenoxane)FDA LinkGeneric 11/01/2015 - "However, these results were very similar to those reported for men who were treated with bleomycin for a male germ cell tumor, suggesting that women with ovarian SCSTs are not particularly vulnerable to bleomycin lung toxicity. "

Therapies and Procedures

1.	Drug Therapy (Chemotherapy) 08/01/2006 - "High-dose chemotherapy for male germ cell tumor." 01/01/1990 - "We identified 14 male germ cell tumor patients (13 of whom had received prior chemotherapy) in whom distinctive neoplasms composed of spindle to stellate cells set in a myxoid to collagenous stroma containing numerous blood vessels developed. " 10/01/2006 - "Although the usefulness of high-dose chemotherapy with peripheral blood stem cell transplantation for advanced germ cell tumor is still under evaluation in phase III randomized controlled studies, this approach is currently used as one treatment option for relapsed or advanced male germ cell tumor. " 12/01/2005 - "To evaluate the feasibility and usefulness of high dose chemotherapy including paclitaxel (T-ICE) combined with peripheral blood stem cell transplantation (PBSCT) for male germ cell tumor. " 12/01/2005 - "High dose chemotherapy including paclitaxel (T-ICE) combined with peripheral blood stem cell transplantation for male germ cell tumor. "
2.	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 10/01/2006 - "Although the usefulness of high-dose chemotherapy with peripheral blood stem cell transplantation for advanced germ cell tumor is still under evaluation in phase III randomized controlled studies, this approach is currently used as one treatment option for relapsed or advanced male germ cell tumor. " 12/01/2005 - "To evaluate the feasibility and usefulness of high dose chemotherapy including paclitaxel (T-ICE) combined with peripheral blood stem cell transplantation (PBSCT) for male germ cell tumor. " 12/01/2005 - "High dose chemotherapy including paclitaxel (T-ICE) combined with peripheral blood stem cell transplantation for male germ cell tumor. " 10/01/2006 - "Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience."